TALL CELL VARIANT THYROID GLAND PAPILLARY CARCINOMA

Clinical trials for TALL CELL VARIANT THYROID GLAND PAPILLARY CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new TALL CELL VARIANT THYROID GLAND PAPILLARY CARCINOMA trials appear

Sign up with your email to follow new studies for TALL CELL VARIANT THYROID GLAND PAPILLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to tame tough thyroid cancers

Disease control Ongoing

This study is testing whether a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—can help control advanced thyroid cancer that has stopped responding to radioactive iodine and has worsened after one prior targeted therapy. The goal is to see if this three-drug a…

Matched conditions: TALL CELL VARIANT THYROID GLAND PAPILLARY CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

TALL CELL VARIANT THYROID GLAND PAPILLARY CARCINOMA

Get alerted when new TALL CELL VARIANT THYROID GLAND PAPILLARY CARCINOMA trials appear

New drug combo aims to tame tough thyroid cancers